article thumbnail

Health spending spikes in Massachusetts amid high drug expenses, unprecedented patient cost sharing, regulator warns

Fierce Healthcare

Pharmaceutical costs, non-claims payments and outpatient care fueled “unchecked” healthcare spending in Massachusetts that's increasingly being felt by its residents, according to new findings from | The Bay State's healthcare cost growth benchmark program is calling for policy action after a report showed per-person health spending well (..)

article thumbnail

Leveraging Technology to Improve Pharmaceutical Oversight and Patient Safety

HIT Consultant

In a time when healthcare is always changing, the pharmaceutical sector is under more pressure to ensure patient safety while maintaining compliance with stringent regulatory standards. As the complexity of pharmaceutical delivery rises, technology has become ever more crucial in tracking and safeguarding pharmacological products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Best Practices for Conquering Data Management Challenges in the Pharma Industry

HIT Consultant

But it’s especially difficult in an industry like pharmaceuticals, due both to the sensitivity of the data and the severity of consequences that result from data management mistakes. Best practices for managing pharmaceutical data Again, there are no simple solutions for streamlining data management in the pharmaceutical industry.

article thumbnail

How Pharmaceuticals Can Unlock the Power of Influencer Marketing

Healthcare Success

But with all the regulations, can pharmaceutical marketers really utilize influencers to reach consumers and HCPs? This episode is essential listening for pharmaceutical and other healthcare leaders looking for modern ways to engage their audience, increase brand awareness, and boost sales. I'm a pharmaceutical physician.

article thumbnail

Why is the market design for innovative pharmaceuticals not well understood?

Healthcare ECONOMIST

A lot of people when they look at pharmaceutical prices think they are ‘too high’ or ‘too low’ But the question is, too high or too low relative to what? What are our goals in pharmaceutical pricing. That is the title of a fantastic editorial from Olivença et al.

article thumbnail

Intel, ConsenSys Health combine blockchain and AI for clinical trials management

Healthcare It News

Matching patients to clinical trials they are eligible for has been a major challenge for everyone from pharmaceutical companies to hospitals. " One of the major reasons clinical trial-matching and recruitment is so slow is that it's largely limited by laws and regulations related to patient privacy. THE PROBLEM.

article thumbnail

Health care in Spain

Healthcare ECONOMIST

of individuals >15 were daily smokers Alcohol use : 6% of adults regularly engage in heavy drinking (below EU average of 18.5%) [link] Healthcare spending Healthcare spending : €132 billion (as of 2021) Healthcare spending as a share of GDP : 10.8% (as of 2021) Pharmaceutical spending : €12.7 Country overview Population : 48.4